Cerebral Autosomal Dominant Arteriopatie With Subcortical Infarcts and Leukoencephalopathy

1

Review clinical trials related to Cerebral Autosomal Dominant Arteriopatie With Subcortical Infarcts and Leukoencephalopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Prospective Study of Korean CADASIL Patients

K-CADASIL is a 10-year prospective study of 500 Korean patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a genetic brain disease that causes stroke and dementia. The investigators will track symptoms, brain scans, memory tests, and gene information to understand disease progression in Koreans and identify better treatments. Participants will visit clinics regularly for check-ups and blood tests. This study aims to help improve care for CADASIL patients and families worldwide.

Participants needed: 500
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Jeju National University HospitalUpdated: May 14, 2026Locations: 1Duration: 10 Years
Eligibility criteria

Age ≥ 19 years [+2]

Contraindication to MRI (claustrophobia, metal implants, pacemaker) [+1]